Amylyx Pharmaceuticals
Price & Volume
Stats
See more52W Range | $2.60-$15.14 |
Market Cap | $1.5B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | -$249,000 |
Revenue Growth (YoY) | -99.6% |
Gross Profit (12 Mos) | -$94.5M |
Diluted EPS | -$2.56 |
News
See moreYahoo Finance • 21 days ago
Amylyx Pharmaceuticals prices $175M public offering
Yahoo Finance • last month
Amylyx drops clinical program for neuro disorder after trial readout
Yahoo Finance • last month
Amylyx Pharmaceuticals discontinues ORION program for AMX0035 in PSP
Yahoo Finance • 2 months ago
Amylyx anticipates Avexitide Phase III data in H1 2026 while expanding rare disease pipeline
About
CEO | Mr. Joshua B. Cohen |
Address | 43 Thorndike Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 123 |
